Clinlogix Expands Safety Services

Published: Oct 15, 2012

Spring House, PA (October 12, 2012) -- Clinlogix, a clinical research organization located just outside Philadelphia, is taking steps to broaden the services they provide by bringing Julie McCusker, R.pH. onboard as the Senior Director, Safety Services. In recent years, pharmaceutical, biotech, and medical device companies have begun to outsource portions, or all, of their clinical trials. With this recent trend, clinical research organizations have grown in importance as they help complete these clinical trials.

On October 1, 2012, Julie McCusker joined Clinlogix to kick-off their Safety Services. Julie is a Registered Pharmacist with a broad and deep understanding of the biopharmaceutical and medical device industries. She began her pharmacovigilance and medical information career over fifteen (15) years ago at a large consumer products company. She later advanced her skills in managing drug safety initiatives for small and large prescription drug companies and contract research organizations. This background has more than prepared her to excel in her new position at Clinlogix.

“I am excited to be part of company with such integrity,” said Julie McCusker. “Product safety needs to get back to its roots of exceptional data quality, with the combination of people, process and technology. Clinlogix is poised to deliver high-quality, on time and on budget. Safety services for devices, products and drugs are quickly changing in the safety arena. From case processing through aggregate reporting and one-off safety projects, Clinlogix’s experienced project team, is client focused and delivers results.”

JeanMarie Markham, President and CEO of Clinlogix, stressed the importance of the new service saying, “As outsourcing continues to be the norm, and the proliferation of small biopharmaceutical and medical device companies continues, it is becoming increasingly imperative for companies to have a strategic partner that can provide a web-based safety management platform via a proven, validated technology such as Oracle Argus to successfully meet regulatory compliance, at an affordable price point. It is not sufficient, though to have the technology; it must be coupled with a highly skilled and proficient safety team to maximize the effectiveness of the program.”

Clinlogix uses Oracle Argus supported by Sentrx, the industry leaders in pharmacovigilance solutions. The safety system, coupled with our new Senior Director, Safety Services, will allow the company to compete in a new field.

About Clinlogix

Clinlogix, a clinical research organization, provides comprehensive clinical development services for pharmaceutical, biotech and medical device companies engaged in clinical programs. A global service provider founded in 1999, Clinlogix supports and services clinical development of drugs, biologics, devices and diagnostics in Discovery and Phase I through IV clinical trials, complying with worldwide regulatory requirements. Clients choose either full-service clinical development or functional services as they need. Certified by the Women’s Business Enterprise National Council, Clinlogix succeeds in delivering quality and compliant results, on time and on budget. For more information, please visit

For more information about Clinlogix, or to schedule a meeting, please contact Clinlogix by email: , by phone: (215) 855-9054, or visit Clinlogix’s website:

Back to news